TGFB1 and neoplasm: Upon administration, TGFβ-15 aims to restore and enhance an immunological anti-tumor response by stimulating the host immune system to mount a cytotoxic T-lymphocyte response against TGFβ-expressing immunosuppressive cells in the TME, including TAMs, MDSCs, DCs, Tregs, and CAFs.